The Chemosensitizer market is a subset of the Oncology Drugs market, which focuses on drugs that increase the effectiveness of chemotherapy treatments. Chemosensitizers are used to make cancer cells more sensitive to chemotherapy drugs, allowing for more effective treatment. These drugs are typically used in combination with chemotherapy to increase the effectiveness of the treatment. Chemosensitizers can also be used to reduce the side effects of chemotherapy, such as nausea and vomiting.
Chemosensitizers are used in a variety of cancer types, including breast, lung, and colorectal cancer. They are also used in combination with other treatments, such as radiation therapy and immunotherapy.
The Chemosensitizer market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more
